Glenmark Pharma wins patent war with Abbott, India’s patent office rescinds patent for Humira

Following opposition by Mumbai-based generic-drug maker Glenmark Pharmaceuticals, India’s patent office has rescinded a patent granted to Abbott Biotechnology Ltd. for rheumatoid arthritis drug Humira,